Phillip Brian Smith

476 total citations
10 papers, 325 citations indexed

About

Phillip Brian Smith is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Phillip Brian Smith has authored 10 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in Pharmacology. Recurrent topics in Phillip Brian Smith's work include Antifungal resistance and susceptibility (4 papers), Pharmaceutical studies and practices (4 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Phillip Brian Smith is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Pharmaceutical studies and practices (4 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Phillip Brian Smith collaborates with scholars based in United States and United Kingdom. Phillip Brian Smith's co-authors include Daniel K. Benjamin, Kelly C. Wade, Michael Cohen‐Wolkowiez, Ian M. Paul, Gregory L. Kearns, Edmund V. Capparelli, Katherine Berezny, Jeff Barrett, Matthew M. Laughon and Melanie C. Wright and has published in prestigious journals such as The Journal of Pediatrics, Neuropharmacology and The Pediatric Infectious Disease Journal.

In The Last Decade

Phillip Brian Smith

10 papers receiving 310 citations

Peers

Phillip Brian Smith

PPCH

ID

PRM

PHARM

EPIDE

Rachel Meyers United States

Michael A. Fotis United States

Chien‐Chih Wu Taiwan

A. Mary Vilay United States

Allison Forni United States

Jane Hodding United States

Carmela Corallo Australia

Mariann D. Churchwell United States

Nienke J. Vet Netherlands

Pavla Pokorná Czechia

Rachel Meyers United States

Phillip Brian Smith

125 ×1.0

PPCH

50 ×0.5

ID

42 ×0.5

PRM

43 ×0.6

PHARM

33 ×0.5

EPIDE

Citations per year, relative to Phillip Brian Smith Phillip Brian Smith (= 1×) peers Rachel Meyers

Countries citing papers authored by Phillip Brian Smith

Since Specialization

Citations

This map shows the geographic impact of Phillip Brian Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Brian Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Brian Smith more than expected).

Fields of papers citing papers by Phillip Brian Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Brian Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Brian Smith. The network helps show where Phillip Brian Smith may publish in the future.

Co-authorship network of co-authors of Phillip Brian Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Brian Smith. A scholar is included among the top collaborators of Phillip Brian Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Brian Smith. Phillip Brian Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Goldberg, Lisa R., et al.. (2022). Genetic differences in nicotine sensitivity and metabolism in C57BL/6J and NOD/ShiLtJ mouse strains. Neuropharmacology. 221. 109279–109279. 3 indexed citations

2.

Barbara, T., Abhik Das, P. Brian Smith, et al.. (2019). Gastrostomy Tube Feeding in Extremely Low Birthweight Infants: Frequency, Associated Comorbidities, and Long-term Outcomes. The Journal of Pediatrics. 214. 41–46.e5. 30 indexed citations

3.

McMahon, Ann, Renan A. Bonnel, Daniela Testoni, et al.. (2015). Pediatric post-marketing safety systems in North America: assessment of the current status. Pharmacoepidemiology and Drug Safety. 24(8). 785–792. 10 indexed citations

4.

Hornik, Christoph P., Patricia Y. Chu, Jennifer S. Li, et al.. (2014). Comparative Effectiveness of Digoxin and Propranolol for Supraventricular Tachycardia in Infants*. Pediatric Critical Care Medicine. 15(9). 839–845. 15 indexed citations

5.

Smith, Phillip Brian, et al.. (2011). Safety of micafungin in infants: insights into optimal dosing. Expert Opinion on Drug Safety. 10(2). 281–286. 22 indexed citations

6.

Laughon, Matthew M., Daniel K. Benjamin, Edmund V. Capparelli, et al.. (2011). Innovative clinical trial design for pediatric therapeutics. Expert Review of Clinical Pharmacology. 4(5). 643–652. 96 indexed citations

7.

Wright, Melanie C., et al.. (2011). Adaptation of a Postoperative Handoff Communication Process for Children With Heart Disease. American Journal of Medical Quality. 26(5). 380–386. 47 indexed citations

8.

Wade, Kelly C., Daniel K. Benjamin, David Kaufman, et al.. (2009). Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants. The Pediatric Infectious Disease Journal. 28(8). 717–723. 80 indexed citations

9.

Cohen‐Wolkowiez, Michael, Cassandra Moran, Daniel K. Benjamin, & Phillip Brian Smith. (2009). Pediatric antifungal agents. Current Opinion in Infectious Diseases. 22(6). 553–558. 18 indexed citations

10.

Smith, Phillip Brian, et al.. (2005). Neonatal candidiasis: prophylaxis and treatment. Expert Opinion on Pharmacotherapy. 6(10). 1647–1655. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact